Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | LDLR | P01130 | 8/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13976141 | 0.84 | ALDH1A1 (0.48) | MGLLALDH1A1LMNAMAPK1LDLR | |
| SCHEMBL13966760 | 0.84 | ALDH1A1 (0.48) | MGLLALDH1A1LMNAMAPK1LDLR | |
| SCHEMBL21675994 | 0.84 | ALDH1A1 (0.48) | MGLLALDH1A1LMNAMAPK1LDLR | |
| SCHEMBL10192097 | 0.82 | MGLL (0.63) | MGLLALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL17344408 | 0.81 | MGLL (0.73) | MGLLALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL1841204 | 0.80 | NPC1 (0.64) | MGLLALDH1A1LMNAMAPK1LDLR | |
| SCHEMBL473082 | 0.79 | NLRP3 (0.66) | ALDH1A1LMNAMAPK1NLRP3NPC1 | |
| SCHEMBL11419125 | 0.79 | LMNA (0.57) | ALDH1A1LMNAMAPK1NLRP3NPC1 | |
| SCHEMBL12407168 | 0.78 | PTGIR (0.53) | MGLLALDH1A1LMNANPC1TSHR | |
| SCHEMBL4966292 | 0.77 | NPC1 (0.64) | MGLLALDH1A1LMNAL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10338290-B2 | Cellulose ester film, polarizing plate, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2019-07-02 | — | — | US | disclosed |
| US-10040754-B2 | Cellulose acylate film, novel compound, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2018-08-07 | — | — | US | disclosed |
| US-20160370522-A1 | CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160060405-A1 | POLYMER FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20150361036-A1 | CELLULOSE ACYLATE FILM, NOVEL COMPOUND, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10040754-B2 | Cellulose acylate film, novel compound, polarizing plate and liquid crystal display device | NR1D1, NR1H2, NR1D2 | MGLL 329/4885ALDH1A1 3058/4885LMNA 1344/4885 |
| US-20150361036-A1 | CELLULOSE ACYLATE FILM, NOVEL COMPOUND, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | NR1D1, NR1H2, NR1D2 | MGLL 329/4885ALDH1A1 3058/4885LMNA 1344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.